Kimberly Manhard

2019

In 2019, Kimberly Manhard earned a total compensation of $2.5M as Executive Vice President, Drug Development at Heron Therapeutics, a 3% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$196,054
Option Awards$1,815,276
Salary$490,136
Other$8,400
Total$2,509,866

Manhard received $1.8M in option awards, accounting for 72% of the total pay in 2019.

Manhard also received $196.1K in non-equity incentive plan, $490.1K in salary and $8.4K in other compensation.

Rankings

In 2019, Kimberly Manhard's compensation ranked 4,843rd out of 13,971 executives tracked by ExecPay. In other words, Manhard earned more than 65.3% of executives.

ClassificationRankingPercentile
All
4,843
out of 13,971
65th
Division
Manufacturing
1,808
out of 5,701
68th
Major group
Chemicals And Allied Products
630
out of 2,200
71st
Industry group
Drugs
530
out of 1,886
72nd
Industry
Pharmaceutical Preparations
397
out of 1,398
72nd

Pay ratio

Kimberly Manhard's Pay$2,509,866
Median Employee's Pay$408,623
Pay Ratio

6

to 1

In 2019, the annual total compensation of Kimberly Manhard was $2,509,866.

The annual total compensation of the median employee at Heron Therapeutics was $408,623.

The ratio of Kimberly Manhard's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 23, 2020.

Manhard's colleagues

We found four more compensation records of executives who worked with Kimberly Manhard at Heron Therapeutics in 2019.

2019

Barry Quart

Heron Therapeutics

Chief Executive Officer

2019

John Poyhonen

Heron Therapeutics

Executive Vice President, Chief Commercial Officer

2019

Robert Hoffman

Heron Therapeutics

Chief Financial Officer

2019

Robert Rosen

Heron Therapeutics

Former President

News

In-depth

You may also like